The William Harvey Research Institute at Queen Mary University of London is one of the largest multidisciplinary pharmacological institutes in Europe that was founded in 1986 by the pharmacologist Sir John Vane FRS, Nobel Laureate, for his work on inflammation and vascular pharmacology. Today the Institute has three key themes of cardiovascular, inflammation and endocrine research and has grown to 350 in number, drawing from over 45 Nations.
We host 9 British Heart Foundation/Wellcome/MRC Programmes Awards, 2 European Union Framework (EU) 7 Programmes (11m Euros). Importantly, we place a major emphasis on training the next top class cadre of basic and clinical scientists and through the award of prestigious PhD/ Masters programmes from the British Heart Foundation, the Nuffield Foundation Oliver Bird scheme, an MRC in vivo programme and an EU Marie Curie Cofund scheme (6.5m Euros) we have created the WHRI Translational Academy for Therapeutic Innovation to educate and train the researchers of the future.
Our commitment to translation of bench findings to the clinic is reflected by our successes in hosting two consecutive awards for a National Institute for Health Research Cardiovascular Biomedical Research Unit (£12m), an Arthritis Research UK Early Arthritis Treatment Centre, an MRC Centre in Electronic Health based around innovative trial designs with remote follow-up, alongside opening a £25m new Heart Centre. A reflection of our success in translation is exemplified by our critical role in launching the new NICE guidelines for pharmacotherapy in Hypertension and implementing our research in renal denervation for resistant hypertension within the NHS. This is set alongside an active public engagement programme ranging from organising the Queen Mary Science Festival and exhibiting at the Royal Society Summer School aimed at enthusing the next generation of therapeutic innovators.
Our main areas of research are aligned and integrated with the main themes pursued across Barts & The London School of Medicine & Dentistry. These include:
- Genomics & Stratified Medicine
- Experimental Medicine & Pharmacology
- Translational Pharmacology & Therapeutic Innovation
- Centre for Biochemical Pharmacology
- Centre for Clinical Pharmacology
- Centre for Endocrinology
- Experimental Medicine & Rheumatology
- Centre for Inflammation and Therapeutic Innovation (CiTi)
- Centre for Microvascular Research
- Centre for Advanced Cardiovascular Imaging
- Centre for Translational Medicine & Therapeutics
The William Harvey Research Foundation is a charity promoting and supporting fundamental research into cardiovascular and inflammatory disease, leading to new understanding of the human body, which advances the discovery of new medicines.
This pioneering work is pursued by world-leading scientists at the William Harvey Research Institute. The Foundation seeks to strengthen these efforts to develop innovative treatments by supporting essential research, with new funds for project grants, PhD studentships and academic chairs in recognition of outstanding achievement.
Find out more about the William Harvey Research Foundation.